Leukemias with t(4,11) translocations (MLL-AF4) tend to have elevated levels of prosurvival BCL-2 protein, which counteracts the intrinsic mitochondria-mediated apoptotic pathway (89). The gene discussed is AFF1; the disease is leukemia.